曾勇勤博士在飞利浦工作超过二十年，深耕于医疗健康科技领域近十年，自2006年起担任飞利浦创新高级总监。先后从事科研、创新管理和医疗创新孵化工作，其间涉及影像设备，医疗大数据和人工智能，以及慢病管理等方向；过去4年，曾博士作为飞利浦创投中国团队的负责人，致力于建立飞利浦与外部的创新生态体系，孵化和培育了20余家与飞利浦契合的优秀的医疗创业公司。

曾勇勤博士现担任一所科技职业学院的高层管理职务以分享她的经验给未来的科技从业者；她拥有英国帝国理工学院电子工程博士学位，曾参加过MIT Sloan 的创新高管课程以及由中欧商学院、清华大学和哈佛大学共同讲授的高层管理课程。

曾勇勤博士指导蓝海资本医疗器械、医疗科技等创新领域的研究和投资，并指导、赋能被投企业的产业创新和商业化。

Dr. Yongqin Zeng worked at Philips for more than 20 years, during which she spent 10 years focusing on HealthTech, and she became an innovation senior director since 2006. She worked as a scientist, a leader on HealthTech innovation and on incubation, in the field of medical image equipment, Healthcare big data & medical AI, and chronic disease etc. Over the past four years, Dr. Zeng led Philips Venture China to explore and shape Phillips' external ecosystem with over 20 selected leading HealthTech startups. She is currently serving as a senior role in a technology college and sharing her experiences with future technology specialist.

Dr. Zeng received her Ph.D. in Electronics engineering from Imperial College London, and joined an executive innovation education program from MIT Sloan and a joint senior executive program provided by CEIBS, Tsinghua University and Harvard University.

Dr. Zeng provides BOCG with guidance on the research and investment in medical devices, HealthTech and other innovative areas, and assists and empowers the industrial innovation and portfolio companies' commercialization strategy.